'Hypertension' and 'microalbuminuria': the bell tolls for thee (Q36351684)

13 August 2017

1 reference

title

'Hypertension' and 'microalbuminuria': the bell tolls for thee (English)

1 reference

13 August 2017

main subject

arterial hypertension

0 references

author name string

Forman JP

series ordinal

1

1 reference

13 August 2017

Brenner BM

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

69

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

22-28

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000056

13 August 2017

exact match

0 references

cites work

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Correction of exercise-induced microalbuminuria in insulin-dependent diabetics after 3 weeks of subcutaneous insulin infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Relationship between blood pressure and urinary albumin excretion in development of microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Further evidence for small-bodied hominins from the Late Pleistocene of Flores, Indonesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a "no-salt" culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

A study of blood pressure and body measurements in medical students in the Brazilian Amazon City of Belem

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Serum cholesterol levels of Australians and natives of New Guinea from birth to adulthood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Body fat, blood pressure and serum cholesterol of Australian men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Serum cholesterol and lipoproteins in natives of New Guinea and Australians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Body fat and blood pressure of natives in New Guinea: reflections on essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Some anthropometric and functional dimensions of the pygmy (Kivu Twa).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Aging, acculturation, salt intake, and hypertension in the Kuna of Panama

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Human evolution. Diabetes running wild

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Epidemiologic evidence on the etiology of human hypertension and its possible prevention

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Sick individuals and sick populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Re-examination of some of the Framingham blood-pressure data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

The relation between degree of blood pressure reduction and mortality among hypertensives in the Hypertension Detection and Follow-Up Program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

A likely explanation for the J-curve of blood pressure cardiovascular risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trøndelag Health Study (HUNT), Norway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000056

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000056

1 reference

13 August 2017

1 reference